What are the next steps for a 76-year-old male with visible hematuria (blood in urine) who is asymptomatic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Visible Hematuria in a 76-Year-Old Asymptomatic Male

All patients with visible (gross) hematuria should be promptly referred for urologic evaluation, regardless of whether the bleeding is self-limited, due to the high risk of underlying malignancy (>10%). 1, 2

Initial Assessment in Primary Care

  1. Confirm the presence of hematuria:

    • Perform urinalysis with microscopic examination to confirm hematuria
    • Document number of RBCs per high-power field
    • Do not rely solely on dipstick testing (specificity only 65-99%) 1
  2. Risk stratification:

    • This 76-year-old male is automatically in the high-risk category due to:
      • Age >60 years
      • Male gender
      • Visible (gross) hematuria 1
  3. Initial laboratory workup:

    • Complete blood count
    • Serum creatinine and BUN
    • Urinalysis with microscopic examination
    • Urine culture if infection is suspected 1

Urgent Referral Process

  • Refer for urologic evaluation immediately, even if hematuria is self-limited 3
  • Do not delay referral to complete all testing - this can be coordinated with urology
  • Do not obtain urinary cytology or other urine-based molecular markers for bladder cancer detection in the initial evaluation 3

Important Considerations

  • Pursue evaluation even if patient is on antiplatelet or anticoagulant therapy 3

    • Common misconception: Anticoagulation is not an adequate explanation for hematuria
    • Medications may exacerbate bleeding but rarely cause it without underlying pathology
  • Risk of malignancy:

    • Visible hematuria carries >10% risk of urologic malignancy in this age group 2
    • Risk factors present: age >60 years and male gender 1

Expected Urologic Evaluation

The urologic evaluation will likely include:

  1. Comprehensive imaging:

    • CT Urography (preferred) with contrast enhancement (sensitivity 92%, specificity 93%) 1
    • Alternative imaging if contraindicated:
      • MR Urography (for patients with contrast allergy or renal insufficiency)
      • Renal ultrasound (less sensitive at 50% but 95% specific) 1
  2. Cystoscopy:

    • Direct visualization of bladder and urethra
    • Essential for detecting bladder cancer and other lower urinary tract pathologies 1

Common Pitfalls to Avoid

  • Do not delay referral while completing the workup - this can lead to delayed diagnosis of potentially curable malignancy 4
  • Do not attribute hematuria solely to anticoagulant/antiplatelet medications without proper evaluation 3
  • Do not rely on ultrasound alone as it has limited sensitivity (50%) for detecting urinary tract malignancies 1
  • Do not dismiss self-limited episodes of gross hematuria - they warrant the same thorough evaluation 3, 4

Remember that delaying or deferring a careful investigation of visible hematuria may permit a significant disease process to progress 4.

References

Guideline

Evaluation and Management of Hematuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hematuria.

Primary care, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.